0000905148-23-001029.txt : 20230928 0000905148-23-001029.hdr.sgml : 20230928 20230928191749 ACCESSION NUMBER: 0000905148-23-001029 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230926 FILED AS OF DATE: 20230928 DATE AS OF CHANGE: 20230928 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Mary CENTRAL INDEX KEY: 0001841088 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41551 FILM NUMBER: 231291368 MAIL ADDRESS: STREET 1: C/O BUTTERFLY NETWORK, INC. STREET 2: 530 OLD WHITFIELD STREET CITY: GUILFORD STATE: CT ZIP: 06437 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Acrivon Therapeutics, Inc. CENTRAL INDEX KEY: 0001781174 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 825125532 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL WAY, SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617-207-8979 MAIL ADDRESS: STREET 1: 480 ARSENAL WAY, SUITE 100 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 form4.xml X0508 4 2023-09-26 0001781174 Acrivon Therapeutics, Inc. ACRV 0001841088 Miller Mary C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 true Chief Legal Officer false Common Stock 2023-09-26 4 A 0 3858 0 A 44287 D Stock Option (Right to Buy) 8.95 2023-09-26 4 A 0 11576 0 A 2033-09-25 Common Stock 11576 11576 D These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Of these RSUs, twenty-five percent (25%) shall vest on October 1, 2024, and the remaining RSUs shall vest in three substantially equal annual installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date. Twenty-five percent (25%) of the shares subject to the option shall vest on October 1, 2024, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date. /s/ Rasmus Holm-Jorgensen, Attorney-in-Fact 2023-09-28